Ask Our Doctors and Nurses!

DECADRON Side Effect?
Don't put Your Health at Risk - Take Action Now! Type your question here

 letters left

DECADRON Safety Reports

Total DECADRON reports: 215.
DECADRON FDA safety alerts: No.
Reported deaths: 66    Reported hospitalizations: 106.
Take DECADRON Side Effects Survey or Share Your DECADRON Story. Read More Here.

Showing 1-75 of 215 Next >

Consumer or non-health professional from UNITED STATES reported DECADRON problem on June 14, 2007. Female patient, 48 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: reversible posterior leukoencephalopathy syndrome. DECADRON dosage: unknown. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Consumer or non-health professional from UNITED KINGDOM on June 12, 2007. Male patient, 72 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, multiple myeloma. DECADRON dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, VINCRISTINE SULPHATE, DOXORUBICIN. Patient died.

Consumer or non-health professional from JAPAN reported DECADRON problem on June 18, 2007. Male patient, 30 years of age, was diagnosed with lymphoma, prophylaxis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bronchopleural fistula, lung infection pseudomonal, neutrophil count decreased, pseudomonas infection. DECADRON dosage: unknown. During the same period patient was treated with ETOPOSIDE, AMPICILLIN AND SULBACTAM, TIENAM, MICAFUNGIN. Patient recovered.

DECADRON problem was reported by a Health Professional from GERMANY on June 17, 2007. Male patient, 15 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cerebral thrombosis, hyperammonaemia, hypertriglyceridaemia. DECADRON dosage: unknown. During the same period patient was treated with PEGASPARGASE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported DECADRON problem on June 20, 2007. Female patient, 56 years of age, was diagnosed with addison's disease and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. DECADRON dosage: unknown. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Health Professional from UNITED KINGDOM on June 25, 2007. Male patient, 57 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abdominal discomfort, acanthosis, blood alkaline phosphatase increased, epidermal necrosis, erythema, graft versus host disease, hyperkeratosis, inflammation, lichen planus. DECADRON dosage: unknown. During the same period patient was treated with CYCLOSPORINE, THALIDOMIDE. Patient recovered.

Physician from UNITED STATES reported DECADRON problem on June 21, 2007. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia, prophylaxis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bacterial sepsis, diverticular perforation, gastritis, mucosal inflammation. DECADRON dosage: unknown. During the same period patient was treated with PEGASPARGASE, VINCRISTINE SULPHATE, DOXORUBICIN, RANITIDINE. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on May 30, 2006. Male patient, 68 years of age, was diagnosed with prostate cancer, metastases to bone and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, metastases to bone, osteomyelitis. DECADRON dosage: unknown. During the same period patient was treated with HYPEN, ZOMETA. Patient recovered.

Physician from CANADA reported DECADRON problem on June 26, 2006. Female patient, 69 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: constipation, deep vein thrombosis, neuropathy. DECADRON dosage: unknown. During the same period patient was treated with THALOMID, PANTOPRAZOLE, AREDIA, EPREX. Patient recovered.

DECADRON problem was reported by a Consumer or non-health professional from UNITED STATES on June 19, 2006. Female patient, 49 years of age, weighting 255.0 lb, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cardiac disorder, dysphagia, dyspnoea, oedema peripheral, tongue blistering, tongue disorder. DECADRON dosage: 0.75 MG QDAY PO. During the same period patient was treated with ESTRADIOL, ZOLOFT, MAVIK. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DECADRON problem on July 11, 2006. Female patient, 81 years of age, weighting 215.0 lb, was diagnosed with brain oedema and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: asthenia, bedridden, blood glucose increased, face oedema, muscular weakness, myopathy, oedema peripheral. DECADRON dosage: 4 MG DOWN TO .5MG 4X PER DAY TO 1 PO. Patient died on 07/08/2006.

DECADRON problem was reported by a Health Professional from UNITED STATES on June 26, 2006. Male patient, 65 years of age, was diagnosed with glioblastoma multiforme and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: aspergillosis, asthenia, blood glucose increased, blood sodium decreased, decreased appetite, fatigue, hyperglycaemia, hypoxia, oedema. DECADRON dosage: unknown. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient died on 06/13/2006.

Physician from JAPAN reported DECADRON problem on May 25, 2005. Female patient, 16 years of age, weighting 94.80 lb, was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, acute respiratory distress syndrome, candida sepsis, pneumonia, pyrexia, renal disorder. DECADRON dosage: unknown. During the same period patient was treated with HYDROCORTONE, FILDESIN. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on May 18, 2006. Female patient, 85 years of age, was diagnosed with metastases to bone and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: osteonecrosis, pain in jaw, tooth extraction. DECADRON dosage: unknown. During the same period patient was treated with TAXOTERE, GEMZAR, CARBOPLATIN, CYTOXAN, METHOTREXATE, FLUOROURACIL, DOXIL, ZOMETA. Patient recovered.

Physician from AUSTRALIA reported DECADRON problem on July 18, 2006. Male patient, 70 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, gastrointestinal haemorrhage. DECADRON dosage: unknown. During the same period patient was treated with CARBOPLATIN, DOXORUBICIN, CYTARABINE. Patient died.

DECADRON problem was reported by a Physician from ISRAEL on July 18, 2006. Male patient, 28 years of age, was diagnosed with thrombocytopenia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: appendicitis. DECADRON dosage: unknown. Patient recovered.

Physician from UNITED STATES reported DECADRON problem on June 12, 2006. Female patient, 78 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: dental alveolar anomaly, gingival infection, gingival swelling, gingivitis, osteonecrosis, pain in jaw. DECADRON dosage: 8-10MG QWK. During the same period patient was treated with ZOFRAN, TAXOTERE, XELODA, CYTOXAN, METHOTREXATE, FLUOROURACIL, EPOGEN, ZOMETA. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on May 30, 2006. Male patient, 68 years of age, was diagnosed with prostate cancer, metastases to bone and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, metastases to bone, osteomyelitis. DECADRON dosage: unknown. During the same period patient was treated with HYPEN, ZOMETA, TAXOTERE, CORTICOSTEROIDS. Patient recovered.

Consumer or non-health professional from GERMANY reported DECADRON problem on July 18, 2006. Male patient, 56 years of age, was diagnosed with immunosuppression and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DECADRON dosage: 12 MG/DAILY PO. Patient was hospitalized. Patient died.

DECADRON problem was reported by a Consumer or non-health professional from GERMANY on July 18, 2006. Female patient, 80 years of age, was diagnosed with immunosuppression and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DECADRON dosage: 12 MG/DAILY PO. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DECADRON problem on July 26, 2006. Female patient, weighting 4.41 lb, was diagnosed with histiocytosis haematophagic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: duodenal perforation. DECADRON dosage: unknown. Patient died.

DECADRON problem was reported by a Physician from UNITED STATES on July 13, 2006. Male patient was diagnosed with prostate cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: confusional state. DECADRON dosage: 1 MG PM PO. During the same period patient was treated with ROCALTROL, CARBOPLATIN. Patient recovered.

Health Professional from UNITED STATES reported DECADRON problem on July 11, 2006. Male patient, 52 years of age, was diagnosed with glioblastoma multiforme and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, aggression, anger, aphasia, asthenia, calcinosis, catatonia, cerebral disorder, convulsion. DECADRON dosage: 4 MG Q6H PO. During the same period patient was treated with AMBIEN, ATIVAN, KEPPRA. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on Aug 03, 2006. Male patient, 68 years of age, was diagnosed with multiple myeloma, cardiovascular event prophylaxis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: atelectasis, cholecystitis acute, disease progression, haemorrhage intracranial, hyperglycaemia, international normalised ratio increased, lobar pneumonia, multiple myeloma. DECADRON dosage: unknown. During the same period patient was treated with THALOMID, PLAVIX, ASPIRIN. Patient was hospitalized. Patient died on 03/03/2006.

Health Professional from HONG KONG reported DECADRON problem on Aug 03, 2006. Male patient, 53 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome. DECADRON dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE. Patient recovered.

DECADRON problem was reported by a Health Professional from HONG KONG on Aug 03, 2006. Male patient, 71 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome. DECADRON dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE HYDROCHLORIDE, RITUXIMAB. Patient died.

Health Professional from HONG KONG reported DECADRON problem on Aug 03, 2006. Male patient, 65 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome. DECADRON dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE. Patient died.

DECADRON problem was reported by a Health Professional from HONG KONG on Aug 03, 2006. Female patient, 45 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, myelodysplastic syndrome. DECADRON dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, MITOXANTRONE HYDROCHLORIDE, RITUXIMAB. Patient recovered.

Physician from UNITED STATES reported DECADRON problem on May 18, 2006. Female patient, 85 years of age, was diagnosed with metastases to bone and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone debridement, bone disorder, impaired healing, osteonecrosis, pain in jaw, tooth extraction. DECADRON dosage: unknown. During the same period patient was treated with TAXOTERE, GEMZAR, CARBOPLATIN, CYTOXAN, METHOTREXATE, FLUOROURACIL, DOXIL, ZOMETA. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on July 26, 2006. Female patient, 59 years of age, weighting 176.0 lb, was diagnosed with glioblastoma multiforme and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abasia, asthenia, blood glucose increased, faeces discoloured, hyperosmolar state, nausea, oral intake reduced, retching. DECADRON dosage: 4 MG/BID/PO. During the same period patient was treated with TEMODAR, PREDNISONE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DECADRON problem on Aug 01, 2006. Male patient, 50 years of age, was diagnosed with metastatic malignant melanoma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood calcium increased, blood sodium decreased, blood urea increased, diabetes mellitus non-insulin-dependent, hyperglycaemia, lipase increased. DECADRON dosage: 20 MG PO. During the same period patient was treated with PACLITAXEL, CARBOPLATIN, COUMADIN. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on May 09, 2006. Female patient, 72 years of age, weighting 116.8 lb, was diagnosed with prophylaxis of nausea and vomiting and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hepatitis. DECADRON dosage: unknown. Patient recovered.

Consumer or non-health professional from GERMANY reported DECADRON problem on July 18, 2006. Male patient, 56 years of age, was diagnosed with immunosuppression and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: laboratory test abnormal, pneumocystis jiroveci pneumonia. DECADRON dosage: 12 MG/DAILY. Patient was hospitalized. Patient died.

DECADRON problem was reported by a Consumer or non-health professional from GERMANY on July 18, 2006. Female patient, 80 years of age, was diagnosed with immunosuppression and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pneumocystis jiroveci pneumonia. DECADRON dosage: 12 MG/DAILY PO. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DECADRON problem on June 20, 2006. Male patient, 71 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma, prophylaxis of nausea and vomiting, blood uric acid increased, cancer pain and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bone marrow failure, platelet count decreased, white blood cell count decreased. DECADRON dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, ONCOVIN, KYTRIL, MEYLON, BACTRIM, ALLOPURINOL. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on Aug 23, 2006. Male patient, child 3 years of age, was diagnosed with meningitis listeria and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pyrexia. DECADRON dosage: unknown. During the same period patient was treated with CARBENIN, CEFOTAX, UNASYN, GENTACIN. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DECADRON problem on Mar 07, 2005. Male patient, 51 years of age, weighting 138.9 lb, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: deep vein thrombosis, infection, multiple myeloma, pulmonary embolism. DECADRON dosage: unknown. During the same period patient was treated with THALIDOMIDE, DIFLUCAN, MUCOSTA, BACTRIM. Patient was hospitalized. Patient died on 01/01/2005.

DECADRON problem was reported by a Physician from UNITED STATES on Aug 30, 2006. Male patient, 55 years of age, was diagnosed with hydrocephalus, prophylaxis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: glioblastoma multiforme, hydrocephalus, pneumocystis jiroveci pneumonia, strongyloidiasis. DECADRON dosage: unknown. During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM, LOVENOX. Patient was hospitalized. Patient died.

Health Professional from JAPAN reported DECADRON problem on June 14, 2006. Female patient, 66 years of age, was diagnosed with brain oedema, pancreatic carcinoma metastatic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: condition aggravated, metastases to liver, metastases to lymph nodes, pneumocystis jiroveci pneumonia, tumour marker increased. DECADRON dosage: unknown. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, GLYCEOL. Patient was hospitalized. Patient died on 07/16/2005.

DECADRON problem was reported by a Physician from JAPAN on July 26, 2006. Male patient, weighting 4.41 lb, was diagnosed with histiocytosis haematophagic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cardiac hypertrophy, duodenal perforation. DECADRON dosage: unknown. During the same period patient was treated with DECADRON PHOSPHATE. Patient died on 10/20/2005.

Physician from SWITZERLAND reported DECADRON problem on Sept 01, 2006. Male patient, 55 years of age, was diagnosed with prophylaxis of nausea and vomiting, pneumocystis jiroveci pneumonia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: brain abscess, herpes virus infection, immunosuppression, kaposi's sarcoma, leukopenia, listeriosis, lymphopenia, neutropenia, pneumocystis jiroveci pneumonia. DECADRON dosage: unknown. During the same period patient was treated with PREDNISONE. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on Sept 06, 2006. Female patient, 46 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. DECADRON dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported DECADRON problem on Aug 30, 2006. Female patient was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism. DECADRON dosage: 40 MG/PO. During the same period patient was treated with ASPIRIN, LENALIDOMIDE. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on Sept 06, 2006. Female patient, 46 years of age, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: cerebral infarction. DECADRON dosage: unknown. Patient recovered.

Health Professional from JAPAN reported DECADRON problem on June 14, 2006. Female patient, 66 years of age, was diagnosed with brain oedema, pancreatic carcinoma metastatic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: metastases to liver, metastases to lymph nodes, pneumocystis jiroveci pneumonia. DECADRON dosage: unknown. During the same period patient was treated with GEMCITABINE HYDROCHLORIDE, GLYCEOL. Patient was hospitalized. Patient died on 07/16/2005.

DECADRON problem was reported by a Physician from UNITED STATES on Sept 26, 2006. Male patient, 50 years of age, was diagnosed with brain oedema and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hepatorenal syndrome, respiratory failure. DECADRON dosage: unknown. Patient was hospitalized. Patient died.

Physician from JAPAN reported DECADRON problem on Sept 27, 2006. Male patient, child 10 years of age, was diagnosed with anaplastic large cell lymphoma t- and null-cell types and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: staphylococcal sepsis, therapeutic response decreased. DECADRON dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died.

DECADRON problem was reported by a Physician from JAPAN on Sept 27, 2006. Female patient, child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, herpes zoster disseminated, multi-organ failure. DECADRON dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, LEUNASE, METHOTREXATE. Patient died.

Pharmacist from UNITED STATES reported DECADRON problem on Sept 25, 2006. Male patient, 73 years of age, was diagnosed with prophylaxis of nausea and vomiting and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: bacteria urine, blood bilirubin increased, blood chloride decreased, blood creatine phosphokinase increased, blood glucose increased, blood thyroid stimulating hormone decreased, blood urea increased, cerebral haemorrhage, cerebral infarction. DECADRON dosage: unknown. During the same period patient was treated with EMEND, ALOXI, ETOPOSIDE, ATENOLOL, ATORVASTATIN CALCIUM, CISPLATIN. Patient was hospitalized. Patient died on 02/23/2006.

DECADRON problem was reported by a Health Professional from UNITED KINGDOM on Oct 03, 2006. Male patient, 64 years of age, weighting 183.0 lb, was diagnosed with multiple myeloma, blood pressure increased, analgesic effect and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: toxic epidermal necrolysis. DECADRON dosage: unknown. During the same period patient was treated with THALIDOMIDE, AMLODIPINE BESYLATE, CETIRIZINE, AMILORIDE HYDROCHLORIDE AND FUROSEMIDE, ACETAMINOPHEN AND CODEINE PHOSPHATE, CYCLOPHOSPHAMIDE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from JAPAN reported DECADRON problem on Sept 20, 2006. Female patient was diagnosed with prostate cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pulmonary infarction. DECADRON dosage: 0.5-1.0 MG/DAILY, PO. During the same period patient was treated with CISPLATIN, HORMONES. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, child 10 years of age, was diagnosed with anaplastic large cell lymphoma t- and null-cell types and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: staphylococcal sepsis, therapeutic response decreased. DECADRON dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died.

Physician from JAPAN reported DECADRON problem on Oct 02, 2006. Male patient, 21 years of age, was diagnosed with precursor t-lymphoblastic lymphoma/leukaemia stage iv and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: hepatic steatosis, insulin resistance. DECADRON dosage: unknown. During the same period patient was treated with PREDNISOLONE, CYCLOPHOSPHAMIDE. Patient recovered.

DECADRON problem was reported by a Consumer or non-health professional from JAPAN on Sept 26, 2006. Female patient was diagnosed with prostate cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pulmonary infarction. DECADRON dosage: 0.5-1.0 MG/DAILY PO. During the same period patient was treated with CISPLATIN. Patient recovered.

Physician from UNITED STATES reported DECADRON problem on Oct 11, 2006. Male patient, 34 years of age, was diagnosed with non-hodgkin's lymphoma stage i and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: non-hodgkin's lymphoma, oesophageal perforation, sepsis. DECADRON dosage: unknown. During the same period patient was treated with CYTARABINE, CARBOPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE SULPHATE, PREDNISONE. Patient died.

DECADRON problem was reported by a Physician from UNITED STATES on Oct 11, 2006. Male patient, 32 years of age, was diagnosed with non-hodgkin's lymphoma stage i and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pneumonia, sepsis. DECADRON dosage: unknown. During the same period patient was treated with HYDROXYUREA, CYTARABINE, CISPLATIN, DOXORUBICIN. Patient died.

Health Professional from UNITED KINGDOM reported DECADRON problem on Oct 10, 2006. Female patient, 51 years of age, was diagnosed with ovarian cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: rash macular, swollen tongue, tachycardia. DECADRON dosage: unknown. During the same period patient was treated with CARBOPLATIN, CISPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on Oct 11, 2006. Male patient, 39 years of age, was diagnosed with non-hodgkin's lymphoma stage i and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pneumonia, sepsis. DECADRON dosage: unknown. During the same period patient was treated with METHOTREXATE, BLEOMYCIN, DOXORUBICIN, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE. Patient died.

Health Professional from UNITED KINGDOM reported DECADRON problem on Oct 11, 2006. Female patient, child 7 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: caecitis, constipation, gastroenteritis, intussusception, necrotising colitis. DECADRON dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, child 10 years of age, was diagnosed with anaplastic large cell lymphoma t- and null-cell types and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: staphylococcal sepsis, therapeutic response decreased. DECADRON dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient died.

Consumer or non-health professional from UNITED STATES reported DECADRON problem on Oct 06, 2006. Male patient, 35 years of age, weighting 266.0 lb, was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hepatic enzyme increased. DECADRON dosage: 0.75 MG/DAILY/PO. During the same period patient was treated with KETOCONAZOLE. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on Oct 09, 2006. Female patient was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: actinomycotic pulmonary infection, bone marrow failure, mucormycosis. DECADRON dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DAUNORUBICIN, FOLINIC ACID, HYDROCORTISONE ACETATE, METHOTREXATE, VINCRISTINE SULPHATE. Patient died.

Physician from UNITED STATES reported DECADRON problem on Oct 16, 2006. Female patient, 67 years of age, was diagnosed with mantle cell lymphoma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: infection masked, pseudomonas infection. DECADRON dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE SULPHATE, FILGRASTIM, ALLOPURINOL, ACETAMINOPHEN. Patient died.

DECADRON problem was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, 72 years of age, was diagnosed with mantle cell lymphoma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: infection masked, peritonitis. DECADRON dosage: unknown. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE SULPHATE, FILGRASTIM, ALLOPURINOL, ACETAMINOPHEN. Patient died.

Consumer or non-health professional from JAPAN reported DECADRON problem on June 21, 2005. Female patient was diagnosed with prostate cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: pulmonary embolism, pulmonary infarction. DECADRON dosage: 0.5-1 MG DAILY PO. During the same period patient was treated with CISPLATIN, DIETHYLSTILBESTROL. Patient recovered.

DECADRON problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2006. Female patient was diagnosed with atrioventricular block third degree and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abortion induced, atrioventricular block first degree, atrioventricular block third degree, cardiac disorder, foetal disorder, hydrops foetalis, tricuspid valve incompetence. DECADRON dosage: 4 MG/DAILY/PO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported DECADRON problem on Oct 05, 2006. Female patient was diagnosed with atrioventricular block third degree and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abortion induced, hydrops foetalis. DECADRON dosage: 4 MG/DAILY/PO. Patient recovered.

DECADRON problem was reported by a Physician from AUSTRALIA on Oct 19, 2006. Male patient, 58 years of age, was diagnosed with neck pain, anxiety, depression and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: neuroleptic malignant syndrome. DECADRON dosage: unknown. During the same period patient was treated with DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE, DOXEPIN HYDROCHLORIDE, SINEMET, DIAZEPAM. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported DECADRON problem on Sept 27, 2006. Female patient, child 5 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, disseminated intravascular coagulation, hepatic necrosis, herpes zoster disseminated, multi-organ failure. DECADRON dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, LEUNASE, METHOTREXATE. Patient died.

DECADRON problem was reported by a Health Professional from NORWAY on Oct 17, 2006. Female patient, 63 years of age, was diagnosed with metastases to central nervous system, cerebrovascular accident and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: duodenal ulcer haemorrhage. DECADRON dosage: unknown. During the same period patient was treated with ASPIRIN AND MAGNESIUM OXIDE. Patient died on 02/01/2006.

Consumer or non-health professional from UNITED STATES reported DECADRON problem on Oct 26, 2006. Male patient, 76 years of age, was diagnosed with multiple myeloma and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: blood test abnormal. DECADRON dosage: unknown. During the same period patient was treated with REVLIMID. Patient was hospitalized. Patient recovered.

DECADRON problem was reported by a Physician from UNITED STATES on June 01, 2006. Female patient, 48 years of age, was diagnosed with metastases to bone, breast cancer and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: abscess, inflammation, jaw operation, osteonecrosis, pain, sequestrectomy, tooth extraction. DECADRON dosage: 10MG Q21D. During the same period patient was treated with ZOMETA, TAXOTERE, AVASTIN, XELODA. Patient recovered.

Physician from SWITZERLAND reported DECADRON problem on Oct 26, 2006. Female patient, 74 years of age, was diagnosed with temporal arteritis and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: aspergillosis, cytomegalovirus test, herpes oesophagitis, pneumocystis jiroveci infection, pneumonia klebsiella. DECADRON dosage: unknown. Patient was hospitalized. Patient died.

DECADRON problem was reported by a Health Professional from UNITED KINGDOM on Oct 27, 2006. Male patient, 54 years of age, was diagnosed with leukaemia plasmacytic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: paraesthesia. DECADRON dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, VELCADE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED KINGDOM reported DECADRON problem on Oct 27, 2006. Male patient, 58 years of age, was diagnosed with leukaemia plasmacytic and was treated with DECADRON. After drug was administered, patient experienced the following problems/side effects: herpes zoster disseminated. DECADRON dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, VELCADE. Patient recovered.

Showing 1-75 of 215 Next >